Clinical Research Directory
Browse clinical research sites, groups, and studies.
Impact of Tamsulosin on Post-Operative Urinary Retention Following Pelvic Reconstructive Surgery
Sponsor: Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
Summary
The objective of the study is to determine the effectiveness of postoperative Tamsulosin in reducing the duration of acute postoperative urinary retention (POUR) following pelvic reconstructive surgery through a double blind, randomized placebo-controlled trial.
Official title: The Impact of Tamsulosin on Duration of Post-Operative Urinary Retention in Women Undergoing Pelvic Reconstructive Surgery- A Double Blind, Randomized, Placebo-Controlled Study
Key Details
Gender
FEMALE
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
154
Start Date
2021-11-03
Completion Date
2026-12
Last Updated
2026-03-20
Healthy Volunteers
Yes
Conditions
Interventions
Tamsulosin
Study drug will contain 0.4 mg of Tamsulosin. Subjects will be provided with 10 capsules to be taken daily.
Placebo
Placebo will be prepared by the IDS pharmacist (or contracted pharmacy) and encapsulated in identical appearing wraps. Subjects will be provided with 10 capsules to be taken daily.
Locations (1)
West Penn Hospital
Pittsburgh, Pennsylvania, United States